Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Bart G Jones"'
Autor:
Victoria A Meliopoulos, Lee-Ann Van de Velde, Nicholas C Van de Velde, Erik A Karlsson, Geoff Neale, Peter Vogel, Cliff Guy, Shalini Sharma, Susu Duan, Sherri L Surman, Bart G Jones, Michael D L Johnson, Catharine Bosio, Lisa Jolly, R Gisli Jenkins, Julia L Hurwitz, Jason W Rosch, Dean Sheppard, Paul G Thomas, Peter J Murray, Stacey Schultz-Cherry
Publikováno v:
PLoS Pathogens, Vol 12, Iss 8, p e1005804 (2016)
The healthy lung maintains a steady state of immune readiness to rapidly respond to injury from invaders. Integrins are important for setting the parameters of this resting state, particularly the epithelial-restricted αVβ6 integrin, which is upreg
Externí odkaz:
https://doaj.org/article/34b3f00131f54876a1d6645d45e12018
Autor:
Rajeev Rudraraju, Bart G Jones, Sherri L Surman, Robert E Sealy, Paul G Thomas, Julia L Hurwitz
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86554 (2014)
Morbidity and mortality due to viral infections are major health concerns, particularly when individuals are vitamin A deficient. Vitamin A deficiency significantly impairs mucosal IgA, a first line of defense against virus at its point of entry. Pre
Externí odkaz:
https://doaj.org/article/a0a8d183d54948ed8b1174d7644a9a00
Autor:
Young-In Kim, John P DeVincenzo, Bart G Jones, Rajeev Rudraraju, Lisa Harrison, Rachel Meyers, Jeff Cehelsky, Rene Alvarez, Julia L Hurwitz
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e113100 (2014)
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children and is responsible for as many as 199,000 childhood deaths annually worldwide. To support the development of viral therapeutics and vaccines for
Externí odkaz:
https://doaj.org/article/b7050b9753164fea95b51566b1e0d2e2
Autor:
Crystal W Burke, John N Mason, Sherri L Surman, Bart G Jones, Emilie Dalloneau, Julia L Hurwitz, Charles J Russell
Publikováno v:
PLoS Pathogens, Vol 7, Iss 7, p e1002134 (2011)
The parainfluenza viruses (PIVs) are highly contagious respiratory paramyxoviruses and a leading cause of lower respiratory tract (LRT) disease. Since no vaccines or antivirals exist, non-pharmaceutical interventions are the only means of control for
Externí odkaz:
https://doaj.org/article/63b1c999f15c40a394d4aa77f5a66c26
Autor:
Christina M. Kackos, Sherri L. Surman, Bart G. Jones, Robert E. Sealy, Trushar Jeevan, Christopher J. H. Davitt, Sergei Pustylnikov, Tamarand L. Darling, Adrianus C. M. Boon, Julia L. Hurwitz, Marcelo M. Samsa, Richard J. Webby
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 1 (2023)
ABSTRACT The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in December of 2019 and is responsible for millions of infections and deaths across the globe. Vaccination against SARS-CoV-2 has proven effe
Externí odkaz:
https://doaj.org/article/4e606723ff53413194b0c6a9be5ac4ad
Autor:
Felicia Scaggs Huang, David I. Bernstein, Karen S. Slobod, Allen Portner, Toru Takimoto, Charles J. Russell, Michael Meagher, Bart G. Jones, Robert E. Sealy, Christopher Coleclough, Kristen Branum, Michelle Dickey, Kristen Buschle, Monica McNeal, Mat Makowski, Aya Nakamura, Julia L. Hurwitz
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 2, Pp 554-559 (2021)
SeVRSV is a replication-competent Sendai virus (SeV)-based vaccine carrying the respiratory syncytial virus (RSV) fusion protein (F) gene. Unmanipulated, non-recombinant SeV is a murine parainfluenza virus type 1 (PIV-1) and serves as a Jennerian vac
Externí odkaz:
https://doaj.org/article/0024b08a41a0453eab429c20987a46a3
Autor:
Sherri L. Surman, Bart G. Jones, Rhiannon R. Penkert, Robert E. Sealy, Tony Marion, Paul G. Thomas, Geoffrey Neale, Beisi Xu, Julia L. Hurwitz
Publikováno v:
Viruses, Vol 15, Iss 2, p 482 (2023)
Females often exhibit superior immune responses compared to males toward vaccines and pathogens such as influenza viruses and SARS-CoV-2. To help explain these differences, we first studied serum immunoglobulin isotype patterns in C57BL/6 male and fe
Externí odkaz:
https://doaj.org/article/78738e4b068044f3aed4eafd16a6833c
Autor:
Rhiannon R. Penkert, Melissa Azul, Robert E. Sealy, Bart G. Jones, Jola Dowdy, Randall T. Hayden, Li Tang, A. Catharine Ross, Jane S. Hankins, Julia L. Hurwitz
Publikováno v:
Nutrients; Volume 14; Issue 16; Pages: 3415
Human parvovirus B19 causes life-threatening anemia due to transient red cell aplasia (TRCA) in individuals with sickle cell disease (SCD). Children with SCD experiencing profound anemia during TRCA often require red blood cell transfusions and hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04681f1dc234edc9cd1c24f0620a81a6
Autor:
Robert E. Sealy, Bart G. Jones, Sherri L. Surman, Rhiannon R. Penkert, Stephane Pelletier, Geoff Neale, Julia L. Hurwitz
Publikováno v:
Vaccines, Vol 7, Iss 1, p 26 (2019)
Despite extraordinary advances in fields of immunology and infectious diseases, vaccine development remains a challenge. The development of a respiratory syncytial virus vaccine, for example, has spanned more than 50 years of research with studies of
Externí odkaz:
https://doaj.org/article/811776c87294438fbc9633779108f11a
Autor:
Toru Takimoto, Felicia Scaggs Huang, Michelle Dickey, Karen S. Slobod, David I. Bernstein, Allen Portner, Aya Nakamura, Bart G. Jones, Mat Makowski, Charles J. Russell, Christopher Coleclough, Julia L. Hurwitz, Kristen N Buschle, Kristen Branum, Robert E. Sealy, Michael M Meagher, Monica M. McNeal
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
SeVRSV is a replication-competent Sendai virus (SeV)-based vaccine carrying the respiratory syncytial virus (RSV) fusion protein (F) gene. Unmanipulated, non-recombinant SeV is a murine parainfluenza virus type 1 (PIV-1) and serves as a Jennerian vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::270458babc11b2440438aab3f5edcd23
https://doi.org/10.1080/21645515.2020.1779517
https://doi.org/10.1080/21645515.2020.1779517